Edwards Lifesciences (EW) shares were down nearly 1% in recent trading Thursday after Wolfe Research downgraded the company's stock to underperform from peer perform, with a price target of $60.
Trading volume stood at 4 million shares against a daily average of roughly 5 million.
Price: 69.79, Change: -0.49, Percent Change: -0.70